Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €340k.
No signal scores available.
This profile gathers the share dealings of Agosti Marcello Pignagnoli in Takeda Pharmaceutical Co Ltd. In total, 3 filings cover trades dated from 27 April 2026 to 10 August 2026.
Every open-market trade on record is a sale: 1 sale worth €340k. Other entries cover 2 share grants.
The newest entry dates from 12 August 2026: an open-market sale of €340k, in Takeda Pharmaceutical Co Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations